US Stem Cell Inc (USRM)

[wallas2g1]

I'm with you, except clinical trials is a super expensive undertaking and has the potential to keep out smaller companies with little cash to burn from bringing their products to the market unless they partner with one of the big players. I think they need to focus on Myocell and Myocell SDF until the FDA gets it's act together with clearer guidelines for those in the SVF therapy space.